02/18/2025
5:37 AM | Achilles Therapeutics (Subject)
Coutts Robert William (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2025
4:02 PM | Achilles Therapeutics (Subject)
BML Investment Partners, L.P. (Filed by)
| Form SCHEDULE 13G/A | |
02/11/2025
11:48 AM | Achilles Therapeutics (Subject)
Ehmer Bernhard (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/07/2025
12:32 PM | Achilles Therapeutics (Subject)
Moses Edwin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/06/2025
11:50 AM | Achilles Therapeutics (Subject)
BOESS CARSTEN (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/06/2025
11:55 AM | Achilles Therapeutics (Subject)
Giordano Michael F (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/06/2025
11:39 AM | Achilles Therapeutics (Subject)
O'Neill Julie (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/06/2025
6:15 AM | Achilles Therapeutics (Subject)
Ali Iraj (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/05/2025
1:06 PM | Achilles Therapeutics (Subject)
Quezada Sergio Andres (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/05/2025
11:46 AM | Achilles Therapeutics (Subject)
Coutts Robert William (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/04/2025
5:06 AM | Achilles Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/26/2024
6:22 AM | Achilles Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/02/2024
7:28 AM | Achilles Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/14/2024
8:33 AM | Achilles Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/25/2024
6:14 PM | Achilles Therapeutics (Subject)
BML Investment Partners, L.P. (Filed by)
| Form SC 13G | |
09/19/2024
6:17 AM | Achilles Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/14/2024
7:04 AM | Achilles Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/24/2024
6:00 AM | Achilles Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/17/2024
4:15 PM | Achilles Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/08/2024
6:44 AM | Achilles Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/04/2024
7:12 AM | Achilles Therapeutics (Filer)
| Form 20-F
Registration statement / Annual report / Transition report | |
04/04/2024
7:25 AM | Achilles Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/29/2024
3:30 PM | Achilles Therapeutics (Subject)
Artal International S.C.A. (Filed by)
| Form SC 13G/A | |
Free ACHL Stock Alerts